scholarly journals Regulating the international surrogacy market:the ethics of commercial surrogacy in the Netherlands and India

2020 ◽  
Vol 23 (4) ◽  
pp. 621-630
Author(s):  
Jaden Blazier ◽  
Rien Janssens

Abstract It is unclear what proper remuneration for surrogacy is, since countries disagree and both commercial and altruistic surrogacy have ethical drawbacks. In the presence of cross-border surrogacy, these ethical drawbacks are exacerbated. In this article, we explore what would be ethical remuneration for surrogacy, and suggest regulations for how to ensure this in the international context. A normative ethical analysis of commercial surrogacy is conducted. Various arguments against commercial surrogacy are explored, such as exploitation and commodification of surrogates, reproductive capacities, and the child. We argue that, although commodification and exploitation can occur, these problems are not specific to surrogacy but should be understood in the broader context of an unequal world. Moreover, at least some of these arguments are based on symbolic rhetoric or they lack knowledge of real-world experiences. In line with this critique we argue that commercial surrogacy can be justified, but how and under what circumstances depends on the context. Surrogates should be paid a sufficient amount and regulations should be in order. In this article, the Netherlands and India (where commercial surrogacy was legal until 2015) are case examples of contexts that differ in many respects. In both contexts, surrogacy can be seen as a legitimate form of work, which requires the same wage and safety standards as other forms of labor. Payments for surrogacy need to be high enough to avoid exploitation by underpayment, which can be established by the mechanisms of either minimum wage (in high income countries such as the Netherlands), or Fair-Trade guidelines (in lower-middle income countries such as India). An international treaty governing commercial surrogacy should be in place, and local professional bodies to protect the interests of surrogates should be required. Commercial surrogacy should be permitted across the globe, which would also reduce the need for intended parents to seek surrogacy services abroad.

2020 ◽  
Author(s):  
Juan José Espinal Piedrahita ◽  
Jairo Humberto Restrepo Zea ◽  
Daniel Alberto Grajales Gaviria

Abstract Financial sustainability in health refers to the balance over time between income and expenditure, so expenditure is a major fiscal challenge and its determinants require monitoring. The objective of this study is to define and measure the most important determinants that influence increases in health expenditure in 80 countries at different income levels, and to determine how the average level of increase compares with Colombia. A literature review was conducted to define the determinants. Then, a fixed-effects panel regression model was estimated to reveal the contribution of these determinants to the increase in spending. The results indicate that demographic variables and technological innovation have the greatest impact on the increase in health spending (45% and 43%, respectively). In conclusion, the study validates what is reported in the international literature with regard to upper-middle-income countries, where the evidence identifies that demographic and technological factors have the greatest impact on the increase in spending. There is also a need to include institutional and outcome variables to ensure that a fuller array of health spending determinants are considered, quantified, and explored.


Author(s):  
Pierre-Richard Agénor ◽  
Luiz A. Pereira da Silva

AbstractThis paper discusses the scope for international macroprudential policy coordination in a financially integrated world economy. It begins with a review of the transmission channels associated with, and the empirical evidence on, financial spillovers and spillbacks. Limitations of the existing literature are also identified. The potential gains associated with cross-border macroprudential coordination, dwelling on both recent analytical contributions and quantitative studies based on multi-country models with financial frictions, are then evaluated. The issue of whether coordination of macroprudential policies simultaneously requires some degree of monetary policy coordination is also discussed. The analysis focuses on the potential for policy coordination between major advanced economies and a group identified as systemically-important middle-income countries (SMICs). Next, practical ways to promote international macroprudential policy coordination are considered. Following a discussion of Basel III’s Principle of reciprocity and ways to improve it, the paper advocates a further strengthening of the current statistical, empirical and analytical work conducted by international financial institutions to evaluate, and raise awareness of, the gains from international coordination of macroprudential policies.


Author(s):  
Cas J Isfordink ◽  
Thijs J W van de Laar ◽  
Sjoerd P H Rebers ◽  
Els Wessels ◽  
Richard Molenkamp ◽  
...  

Abstract Background The majority of HCV infections are found in low- and middle-income countries, harboring many region-specific HCV subtypes. Nevertheless, direct-acting antivirals (DAA) trials were almost exclusively conducted in high-income countries, where mainly epidemically spread HCV subtypes are present. Recently, several studies demonstrated sub-optimal DAA efficacy for certain non-epidemic subtypes, which could hamper global HCV elimination. Therefore, we aimed to evaluate DAA efficacy in patients treated for a non-epidemic HCV genotype infection in the Netherlands. Methods We performed a nationwide retrospective study including patients treated with interferon-free DAA for a HCV genotype other than 1a/1b/2a/2b/3a/4a/4d. Genotype was determined by NS5B-region phylogenetic analysis. Primary endpoint was SVR-12. If stored samples were available, NS5A and NS5B sequences were obtained for resistance-associated substitutions (RAS) evaluation. Results We included 160 patients, mainly infected with non-epidemic genotype 2 (41%) and 4 (31%) subtypes. Most patients originated in Africa (45%) or South America (24%); 51 (32%) were cirrhotic. SVR-12 was achieved in 92% (140/152) of patients with available SVR-12 data. Only 73% (8/11) genotype 3 infected patients achieved SVR-12, the majority being genotype 3b patients with 63% (5/8) SVR. Regardless of SVR, all genotype 3b patients had 30K and 31M RAS. Conclusions DAA efficacy in most non-epidemic genotypes in the Netherlands seems reassuring. However, the low SVR-12 rate in subtype 3b infections is alarming, especially as it is common in several HCV endemic countries. Alongside earlier results, our results indicate that a remaining challenge for global HCV elimination is confirming and monitoring DAA efficacy in non-epidemic genotypes.


2020 ◽  
pp. 1791-1802
Author(s):  
Paula Aristizabal ◽  
Luke P. Burns ◽  
Nikhil V. Kumar ◽  
Bianca P. Perdomo ◽  
Rebeca Rivera-Gomez ◽  
...  

PURPOSE Treatment of children with CNS tumors (CNSTs) demands a complex, interdisciplinary approach that is rarely available in low- and middle-income countries. We established the Cross-Border Neuro-Oncology Program (CBNP) between Rady Children’s Hospital, San Diego (RCHSD), and Hospital General, Tijuana (HGT), Mexico, to provide access to neuro-oncology care, including neurosurgic services, for children with CNSTs diagnosed at HGT. Our purpose was to assess the feasibility of the CBNP across the United States-Mexico border and improve survival for children with CNSTs at HGT by implementing the CBNP. PATIENTS AND METHODS We prospectively assessed clinicopathologic profiles, the extent of resection, progression-free survival, and overall survival (OS) in children with CNSTs at HGT from 2010 to 2017. RESULTS Sixty patients with CNSTs participated in the CBNP during the study period. The most common diagnoses were low-grade glioma (24.5%) and medulloblastoma (22.4%). Of patients who were eligible for surgery, 49 underwent resection at RCHSD and returned to HGT for collaborative management. Gross total resection was achieved in 78% of cases at RCHSD compared with 0% at HGT ( P < .001) and was a predictor of 5-year OS (hazard ratio, 0.250; 95% CI, 0.067 to 0.934; P = .024). Five-year OS improved from 0% before 2010 to 52% in 2017. CONCLUSION The CBNP facilitated access to complex neuro-oncology care for underserved children in Mexico through binational exchanges of resources and expertise. Survival for patients in the CBNP dramatically improved. Gross total resection at RCHSD was associated with higher OS, highlighting the critical role of experienced neurosurgeons in the treatment of CNSTs. The CBNP model offers an attractive alternative for children with CNSTs in low- and middle-income countries who require complex neuro-oncology care, particularly those in close proximity to institutions in high-income countries with extensive neuro-oncology expertise.


2016 ◽  
Vol 6 (4) ◽  
pp. 12
Author(s):  
David W. Chapman ◽  
Kaylee Myhre Errecaborde

<p>Faced with increasing pressure to generate more of their own budgets, universities in low and middle income countries are increasingly banding together as country and regional-level networks to bid on and subsequently implement externally funded development projects (a pattern already seen in high income countries). While working as a network may offer a competitive advantage in bidding on international contracts, it also introduces a new set of dynamics in cross border collaboration among higher education institutions. This paper examines the dynamics of university networks, drawing on the experience of one regional and four country-level networks in South East Asia which were created to promote better national preparation and response to pandemic threats. Findings suggest that, in many universities, university efforts to work through networks is a source of considerable controversy as it pushes institutions and individuals into new roles and often conflicts with existing institution-level incentive systems.</p>


2017 ◽  
Vol 2 (7) ◽  
pp. 13-23
Author(s):  
James Dean

Limited access to hearing health care, including hearing aids, is a universal and growing concern. This is particularly true in low- and middle-income countries, such as Mexico. Improving hearing health care equity within a large underserved infant to geriatric population in Mexico requires a foundation of trust and a culturally sensitive vision shared by all stakeholders. This article describes a cross-border hearing health care program that was integrated into an existing humanitarian project for individuals with disabilities. The program, called the Arizona Sonora Borders Projects for Inclusion (ARSOBO), based in Nogales, Sonora, Mexico, is building a “culture of health” in a border town divided by a fence. By crossing geographic, demographic, and social barriers, volunteers from Tucson, Arizona and Nogales, Sonora work to improve the quality of life for hearing impaired individuals, young and old.


2012 ◽  
Author(s):  
Joop de Jong ◽  
Mark Jordans ◽  
Ivan Komproe ◽  
Robert Macy ◽  
Aline & Herman Ndayisaba ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document